Advances in radiation oncology 2024 Apr 27
Neoadjuvant Cemiplimab Followed by Radiation for Locally Advanced, Unresectable Cutaneous Squamous Cell Carcinoma: A Case Report.
Related Questions
If so, would you modify your radiation dose/field size to account for immunotherapy response? After how many cycles?
New comment by Medical Oncologist at Advocate Aurora Health ( October 31, 2025)
That's unfortunate; keep trying, it's certainly an interesting concept.